[Physostigmine therapy in drug toxicity].
D000293:Adolescent; D000328:Adult; D000928:Antidepressive Agents / Q000506:poisoning; D000929:Antidepressive Agents, Tricyclic / Q000506:poisoning; D000978:Antiparkinson Agents / Q000506:poisoning; D001533:Belladonna Alkaloids / Q000506:poisoning; D002648:Child; D002675:Child, Preschool; D003519:Cyclopentolate / Q000506:poisoning; D064420:Drug-Related Side Effects and Adverse Reactions; D006634:Histamine H1 Antagonists / Q000506:poisoning; D006801:Humans; D008875:Middle Aged; D010830:Physostigmine / Q000627:therapeutic use*; D011041:Poisoning / Q000188:drug therapy*; D014149:Tranquilizing Agents / Q000506:poisoning
D000928:Antidepressive Agents; D000929:Antidepressive Agents, Tricyclic; D000978:Antiparkinson Agents; D001533:Belladonna Alkaloids; D006634:Histamine H1 Antagonists; D014149:Tranquilizing Agents; D010830:Physostigmine; D003519:Cyclopentolate
Fysostigmiini lääkeainemyrkytysten hoidossa